Pasithea Therapeutics Corp. (KTTA) stock
KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.07 (-13.14%)
Close on Nov 17, 2026Market cap $14.51MP/E –Yield –
Pasithea Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2022 it was 76.7%, against -14.7% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 76.7% | +91.4 |
| FY2021 | Dec 31, 2021 | -14.7% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2022 | Sep 30, 2022 | 60.4% | – |
| Q2 FY2022 | Jun 30, 2022 | -11.2% | – |
| Q1 FY2022 | Mar 31, 2022 | 5.3% | – |
See a number that looks wrong?